Cargando…

Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction

Drug-drug interactions are one of the major risk factors associated with statin-induced myopathy. Although simvastatin is widely used in Thailand, studies investigating the prevalence of potential simvastatin-drug interactions (SDIs) and its clinical relevance in Thai population are still limited. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siriangkhawut, Methira, Tansakul, Patthana, Uchaipichat, Verawan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605837/ https://www.ncbi.nlm.nih.gov/pubmed/28951665 http://dx.doi.org/10.1016/j.jsps.2016.12.006

Ejemplares similares

Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms
por: Ismail, Sabariah, et al.
Publicado: (2010)

Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAEs
por: Akimoto, Hayato, et al.
Publicado: (2018)

Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia
por: Ballard, Kevin D., et al.
Publicado: (2015)

Sepsis outcomes in patients receiving statins prior to hospitalization for sepsis: comparison of in-hospital mortality rates between patients who received atorvastatin and those who received simvastatin
por: Ouellette, Daniel R, et al.
Publicado: (2015)

Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI
por: Patel, Chinmay, et al.
Publicado: (2019)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Quality assessment of trace Cd and Pb contaminants in Thai herbal medicines using ultrasound-assisted digestion prior to flame atomic absorption spectrometry
por: Siriangkhawut, Watsaka, et al.
Publicado: (2017)

Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin
por: Masadeh, Majed, et al.
Publicado: (2012)

Multicenter Thai university-based surgical ICU study (Thai-SICU study): adverse events and outcome in the SICU
por: Kongsayreepong, S, et al.
Publicado: (2015)

Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression
por: Santos, Tainaê, et al.
Publicado: (2012)

Rhabdomyolysis caused by an unusual interaction between azithromycin and simvastatin
por: Alreja, Gaurav, et al.
Publicado: (2012)

Modified STOP-Bang for predicting perioperative adverse events in the Thai population
por: Sangkum, Lisa, et al.
Publicado: (2021)

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors
por: Khan, Qamar J., et al.
Publicado: (2010)

Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
por: Doshi, Peter, et al.
Publicado: (2022)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Plethora of adverse drug reactions in geriatric population receiving statin therapy for dyslipidaemia
por: Padhye, Mugdha R., et al.
Publicado: (2022)

Adverse Event Circumstances and the Case of Drug Interactions
por: Soldatos, Theodoros G., et al.
Publicado: (2019)

Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
por: Jiao, Xue-feng, et al.
Publicado: (2020)

Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis( )
por: Chuma, Masayuki, et al.
Publicado: (2022)

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis
por: Lee, Eun Bong, et al.
Publicado: (2016)

Prevalence and Factors Associated with Musculoskeletal Disorders among Thai Burley Tobacco Farmers
por: Kongtawelert, Amarin, et al.
Publicado: (2022)

Potential statin-drug interactions: prevalence and clinical significance
por: Zhelyazkova-Savova, Maria, et al.
Publicado: (2014)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
por: Ding, Lingqing, et al.
Publicado: (2022)

Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Statins and Antimicrobial Effects: Simvastatin as a Potential Drug against Staphylococcus aureus Biofilm
por: Graziano, Talita Signoreti, et al.
Publicado: (2015)

Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality
por: Nalin, David R.
Publicado: (1994)

Methods for estimating causal relationships of adverse events with dietary supplements
por: Ide, Kazuki, et al.
Publicado: (2015)

Association of Statin and Its Lipophilicity With Cardiovascular Events in Patients Receiving Chronic Dialysis
por: Wang, Shih‐Wei, et al.
Publicado: (2019)

Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis
por: Eshaghi, Arman, et al.
Publicado: (2019)

Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: going beyond associations
por: Ingle, James N
Publicado: (2010)

Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
por: Jessurun, Naomi T., et al.
Publicado: (2021)

Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline
por: Huesch, Marco D.
Publicado: (2017)

LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand
por: Wiwanitkit, Viroj, et al.
Publicado: (2002)

Causality assessment of adverse events following immunization: the problem of multifactorial pathology
por: Bellavite, Paolo
Publicado: (2020)

Bundled Causal History Interaction
por: Jiang, Peishi, et al.
Publicado: (2020)

Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera
por: Noitem, Rattikarn, et al.
Publicado: (2022)

Comment on "Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data"
por: Kuss, Oliver, et al.
Publicado: (2023)

Solubility enhancement of simvastatin by arginine: thermodynamics, solute–solvent interactions, and spectral analysis
por: Meor Mohd Affandi, MMR, et al.
Publicado: (2016)

Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand
por: Rattanachotphanit, Thananan, et al.
Publicado: (2019)

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mom7ki45horm39s9bepos0r0ok